Hansen Medical Earnings: Here’s Why the Stock is Falling Now

Hansen Medical, Inc. (NASDAQ:HNSN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 10.45%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Hansen Medical, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased to $-0.26 in the quarter versus EPS of $-0.20 in the year-earlier quarter.

Revenue: Decreased 36.56% to $2.95 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Hansen Medical, Inc. reported adjusted EPS loss of $0.26 per share. By that measure, the company missed the mean analyst estimate of $-0.13. It missed the average revenue estimate of $5.76 million.

Quoting Management: “In a little over two quarters, the Company has gone from having just one installed clinical Magellan Robotic System to nine total clinical installations that are involved in treating patients and generating data, as of March 31,” said Bruce Barclay, Hansen Medical’s President and Chief Executive Officer. “I am encouraged by the breadth of clinical applications in the peripheral vasculature and the positive experiences that are being generated at these hospitals. These varied applications are demonstrating the real-world medical utility of Hansen Medical’s systems, and helping to drive further interest and adoption of our technology. Today, we are reporting another quarter of record procedures, marking the seventh consecutive quarter of procedure growth. This is further evidence of the value we believe physicians and hospitals can, and are, experiencing with our intravascular robotic systems. We are particularly encouraged by recent in vitro data and clinical experiences regarding the potential benefits of endovascular robotics in the treatment of carotid artery disease.”

Key Stats (on next page)…

Revenue decreased 32.03% from $4.34 million in the previous quarter. EPS decreased to $-0.26 in the quarter versus EPS of $-0.15 in the previous quarter.

Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0.12 and has not changed. For the current year, the average estimate has moved down from a loss of $0.48 to a loss of $0.51 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)